Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities

Journal of Clinical Virology

Volumn 42, Issue 4, 2008, Pages 353-360

  Pannier Stockman, C ^a   Segard, C ^a   Bennamar, S ^a   Gondry, J ^a   Boulanger, J C ^a   Sevestre, H ^a   Castelain, S ^a   Duverlie, G ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Epidemiology; Genotyping; HPV; Papillomavirus

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DNA SEQUENCE; EPIDEMIOLOGICAL DATA; FEMALE; FRANCE; GENE FREQUENCY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVIX UTERI; DNA, VIRAL; FEMALE; FRANCE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 46149097396     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.03.022     Document Type: Article

References (32)

1. ALTS. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188 (2003) 1383-1392
2. Arbyn M., Sasieni P., Meijer C.J., Clavel C., Koliopoulos G., and Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 Suppl. 3 (2006) S78-S89
3. Boulanger J.C., Sevestre H., Bauville E., Ghighi C., Harlicot J.P., and Gondry J. Epidemiology of HPV infection. Gynecol Obstet Fertil 32 (2004) 218-223
4. Castle P.E., Schiffman M., Burk R.D., Wacholder S., Hildesheim A., Herrero R., et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 11 (2002) 1394-1399
5. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M., et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84 (2001) 1616-1623
6. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S26-S34
7. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
8. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., and El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol 6 (2005) 204
9. Cucherousset J., Bory J.P., Nazeyrollas P., Gabriel R., Quéreux C., Birembaut P., et al. Intérêt du typage HPV dans le dépistage primaire du cancer du col, une expérience sur une série de 10569 femmes. Gynécologie Obstétrique pratique (2003) 153
10. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 Pt 4 (1995) 1057-1062
11. Dumoulin F.L., Nischalke H.D., Leifeld L., von dem Bussche A., Rockstroh J.K., Sauerbruch T., et al. Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J Immunol Methods 241 (2000) 109-119
12. Evander M., Edlund K., Boden E., Gustafsson A., Jonsson M., Karlsson R., et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol 30 (1992) 987-992
13. Evans M.F., Adamson C.S., Papillo J.L., St John T.L., Leiman G., and Cooper K. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 106 (2006) 1054-1064
14. Federschneider J.M., Yuan L., Brodsky J., Breslin G., Betensky R.A., and Crum C.P. The borderline or weakly positive Hybrid Capture II HPV test: a statistical and comparative (PCR) analysis. Am J Obstet Gynecol 191 (2004) 757-761
15. Fuessel Haws A.L., He Q., Rady P.L., Zhang L., Grady J., Hughes T.K., et al. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 122 (2004) 87-93
16. Gonzalez-Bosquet E., Almagro M.M., Mora I., Sunol M., Callejo J., and Lailla J.M. Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology. Eur J Gynaecol Oncol 27 (2006) 135-138
17. Husnjak K., Grce M., Magdic L., and Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 88 (2000) 125-134
18. Kalendar R. FastPCR: a PCR primer design and repeat sequence searching software with additional tools for the manipulation and analysis of DNA and protein; 2006 (www.biocenter.helsinki.fi/bi/programs/fastpcr.htm).
19. Kumar S., Tamura K., and Nei M. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5 (2004) 150-163
20. Manos M.T.Y., Wright D., Lewis A., Broker T., and Wolinsky S. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer cells 7 (1989) 209-214
21. Meijer C.J., Snijders P.J., and Castle P.E. Clinical utility of HPV genotyping. Gynecol Oncol 103 (2006) 12-17
22. Moberg M., Gustavsson I., and Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 41 (2003) 3221-3228
23. Munoz N., Castellsague X., de Gonzalez A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24S3 (2006) S1-S10
24. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
25. Ordi J., Alonso I., Torne A., Esteve R., Sierra E., Campo E., et al. Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?. Gynecol Oncol 99 (2005) 313-319
26. Peyton C.L., Schiffman M., Lorincz A.T., Hunt W.C., Mielzynska I., Bratti C., et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36 (1998) 3248-3254
27. Poljak M. Human papillomaviruses: impact of disease and vaccine intervention. 16th ECCMID. Nice (2006)
28. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 Suppl. 3 (2002) S89-S97
29. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35 (1997) 1304-1310
30. Seme K., Fujs K., Kocjan B.J., and Poljak M. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods 134 (2006) 252-256
31. Speich N., Schmitt C., Bollmann R., and Bollmann M. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 53 (2004) 125-128
32. Vernon S.D., Unger E.R., and Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38 (2000) 651-655